Iovance Biotherapeutics Study Team
Iovance Biotherapeutics
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Iovance Biotherapeutics Study Team as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:13 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT06940739 · A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive LifileucelIovance Biotherapeutics, Inc. · recruiting · Unresectable Melanoma, Metastatic Melanoma, Ocular Melanoma · study director
- Ph1NCT06566092 · Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult ParticipantsIovance Biotherapeutics, Inc. · terminated · Soft Tissue Sarcoma, Primary Central Nervous System Carcinoma, Melanoma · study director
- Ph2NCT06481592 · A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.Iovance Biotherapeutics, Inc. · recruiting · Endometrial Cancer · study director
- Ph3NCT05727904 · Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.Iovance Biotherapeutics, Inc. · recruiting · Metastatic Melanoma, Unresectable Melanoma, Melanoma · study director
- Ph1/Ph2NCT05361174 · A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung CancerIovance Biotherapeutics, Inc. · recruiting · Unresectable Melanoma, Metastatic Melanoma, Stage III Non-small Cell Lung Cancer · study director
- Ph2NCT04614103 · Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung CancerIovance Biotherapeutics, Inc. · recruiting · Metastatic Non Small Cell Lung Cancer · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:13 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in rhabdomyosarcoma.